1. Home
  2. CRMT vs PRQR Comparison

CRMT vs PRQR Comparison

Compare CRMT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$26.24

Market Cap

266.5M

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.99

Market Cap

250.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
PRQR
Founded
1981
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.5M
250.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CRMT
PRQR
Price
$26.24
$1.99
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$37.00
$8.14
AVG Volume (30 Days)
212.9K
658.1K
Earning Date
12-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,381,482,000.00
$18,859,556.00
Revenue This Year
$2.84
N/A
Revenue Next Year
$5.05
$19.56
P/E Ratio
N/A
N/A
Revenue Growth
2.01
N/A
52 Week Low
$17.78
$1.07
52 Week High
$62.72
$3.10

Technical Indicators

Market Signals
Indicator
CRMT
PRQR
Relative Strength Index (RSI) 55.18 40.51
Support Level $24.69 $2.03
Resistance Level $26.74 $2.31
Average True Range (ATR) 1.69 0.17
MACD -0.06 -0.02
Stochastic Oscillator 45.81 13.04

Price Performance

Historical Comparison
CRMT
PRQR

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: